F003 Fifty Shades of Brown: Science, Symptoms, and Strategies for Acquired Pigmentary Disorders
DESCRIPTION
Acquired pigmentary disorders (e.g. post-inflammatory hyperpigmentation, melasma) represent some of the most ubiquitous cutaneous concerns globally. In the U.S. alone, there are about 1.5 million visits for dyschromia annually. Few disease phenotypes are as visually compelling, or as challenging to treat, as chronic hyperpigmentation. Recent insights into melanocyte biology coupled with both rapid advances in molecular and biologic therapeutics and breakthroughs in device technology have now yielded unprecedented opportunities to “personalize” a corrective regimen. Clinical cases will be used to illustrate the mechanistic underpinnings of common acquired pigmentary conditions along with the latest medical and surgical strategies for treatment.
LEARNING OBJECTIVES
Define the proper methods for diagnosing and documenting acquired dyschromias in patients with various ethnic backgrounds.
Discuss the most recent scientific breakthroughs in our understanding of normal melanocyte biology and abnormal pigment physiology.
Formulate medical, surgical, or combination treatment strategies for common acquired pigmentary conditions.
DIRECTOR
Sandy Sharon Tsao, MD, FAAD
DISCLOSURES
Sandy Sharon Tsao, MD, FAAD
Beiersdorf, Inc. – Consultant (1099 relationship)(Honoraria); Epiphany Dermatology – Advisory Board(Stock); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);